Dr. Rajesh Sharma, MD
What this data tells you about Dr. Sharma
Dr. Rajesh Sharma is an interventional pain medicine physician in Boerne, TX, with 15 years in practice. Based on federal Medicare data, Dr. Sharma performed 8,448 Medicare services across 2,681 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharma received a total of $90,888 from 27 pharmaceutical and/or device companies across 447 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging, lower concentration | 3,230 | $0 | $10 |
| Dexamethasone injection (steroid) | 794 | $0 | $10 |
| Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 491 | $1 | $7 |
| Injection, methylprednisolone acetate, 40 mg | 441 | $6 | $70 |
| Injection, midazolam hydrochloride, per 1 mg | 378 | $0 | $20 |
| Injection, methylprednisolone acetate, 80 mg | 329 | $9 | $80 |
| Office visit, established patient (30-39 min) | 287 | $92 | $321 |
| Injection, cefazolin sodium, 500 mg | 227 | $1 | $10 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 183 | $188 | $948 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 181 | $99 | $480 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 155 | $38 | $147 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 123 | $465 | $2,248 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 118 | $222 | $923 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 116 | $260 | $914 |
| Testing for presence of drug, read by direct observation | 109 | $12 | $100 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 99 | $189 | $915 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 99 | $97 | $449 |
| Destruction of peripheral nerve or branch | 75 | $143 | $552 |
| Assessment of emotional or behavioral problems | 69 | $3 | $15 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 68 | $85 | $288 |
| Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 66 | $24 | $106 |
| New patient office visit (45-59 min) | 64 | $109 | $483 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 60 | $8 | $30 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 56 | $48 | $206 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 50 | $139 | $678 |
| Fluoroscopic guidance for needle placement | 50 | $89 | $293 |
| Injection of substance into middle or upper spine canal using imaging guidance | 48 | $179 | $740 |
| Injection, methylprednisolone acetate, 20 mg | 47 | $5 | $50 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 40 | $252 | $851 |
| Office visit, established patient (20-29 min) | 38 | $69 | $217 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 36 | $90 | $419 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 36 | $32 | $264 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 36 | $420 | $2,079 |
| Insertion of spinal neurostimulator electrode array through skin | 35 | $1,324 | $4,701 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 29 | $692 | $13,722 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 29 | $41 | $200 |
| Treatment of broken lower spine bone with placement of stabilizing device | 26 | $4,357 | $19,799 |
| Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | 23 | $172 | $735 |
| Imaging guidance for procedure, 60 minutes or less | 20 | $33 | $136 |
| Injection of substance into lower spine canal using imaging guidance | 17 | $197 | $731 |
| Joint injection, major joint | 15 | $33 | $189 |
| Treatment of broken middle spine bone with placement of stabilizing device using imaging guidance | 15 | $4,390 | $17,000 |
| Insertion of spinal neurostimulator generator or receiver | 15 | $156 | $1,073 |
| Destruction of nerve branches of knee using imaging guidance | 13 | $333 | $1,662 |
| Review by radiologist of hip joint image | 12 | $100 | $325 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (41%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional pain medicine physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for interventional pain medicine physician in TX.
Geographic Context
20.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sharma is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (speaking/promotional, top 4%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with contrast dye for imaging, lower concentration?
Does Dr. Sharma receive payments from pharmaceutical companies?
How do Dr. Sharma's costs compare to other interventional pain medicine physicians in Boerne?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology